National
Big Pharma executives are cashing in as COVID-19 vaccine race sends shares surging – Sydney Morning Herald
Moderna is one of many companies in the race to find a COVID-19 vaccine. In the meantime, its chief executive is pocketing millions of dollars every month by selling shares that have tripled in price.
Bancel set a fixed schedule for his share sales – known as a 10b5-1 plan – long before the pandemic hit. Such executive share-sale plans are meant to guard against insider trading, avoiding the poten…
